Judge Tosses Biogen MS Drug Antitrust Suit, For Now
By Matthew Perlman · June 26, 2025, 5:09 PM EDT
An Illinois federal court tossed a proposed class action accusing Biogen of reducing competition for its multiple sclerosis drug Tecfidera through payments to pharmacy benefit managers, after finding that only some...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login